-Event to be webcast live and a
replay will be available
SAN
RAFAEL, Calif., Aug. 19,
2024 /PRNewswire/ -- BioMarin Pharmaceutical
Inc. (NASDAQ: BMRN) will host an Investor Day with financial
analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time. The event
will feature presentations from members of the executive management
team and will highlight BioMarin's pipeline, strategic plans,
growth opportunities and long-term financial outlook.
BioMarin will host a live webcast on Wednesday, September 4, 2024, at approximately
10:30 am Eastern Daylight Time.
Presentation materials will also be available at
investors.biomarin.com. A replay of the webcast will be available
online shortly after the live webcast is completed.
About BioMarin
Founded in 1997, BioMarin is a global
biotechnology Company dedicated to transforming lives through
genetic discovery. The Company develops and commercializes targeted
therapies that address the root cause of genetic
conditions. BioMarin's unparalleled research and development
capabilities have resulted in eight transformational commercial
therapies for patients with rare genetic disorders. The Company's
distinctive approach to drug discovery has produced a diverse
pipeline of commercial, clinical, and pre-clinical candidates that
address a significant unmet medical need, have well-understood
biology, and provide an opportunity to be first-to-market or offer
a substantial benefit over existing treatment options. For
additional information, please visit www.biomarin.com.
Contacts:
|
|
Investors
|
Media
|
Traci McCarty
|
Marni Kottle
|
BioMarin Pharmaceutical Inc.
|
BioMarin Pharmaceutical Inc.
|
(415)
455-7558
|
(650)
374-2803
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-2024-investor-day-on-september-4th-in-new-york-302224592.html
SOURCE BioMarin Pharmaceutical Inc.